Glaucoma Clinical Trial
Official title:
Psychopathology of Normal-tension Glaucoma in Hong Kong Chinese Out-patient
Verified date | August 2009 |
Source | Chinese University of Hong Kong |
Contact | n/a |
Is FDA regulated | No |
Health authority | Hong Kong: Ethics Committee |
Study type | Observational |
It is suggested the pathogenesis of normal-tension glaucoma (NTG) involves vascular
dysregulation. In the past studies, it is well documented that many physical problems
related to vascular dysregulation, such as angina pectoris (Friedman M et al 1974; Russek HI
et al 1976), migraine (Diener HC et al 1994), primary Raynaud's disease (Wagner HH et al
1993) and stroke (Gainotti G, et al, 2001; Hayee Ma et al 2001), are associated with a high
risk of depressive illness. So, NTG, being a disease involving vascular dysregulation, is
postulated to be associated with psychopathology.
Glaucoma increases after 40 year-old and the number of people over this age in Hong Kong is
rapidly growing. However, we have no knowledge about the link between psychopathology and
NTG in Hong Kong. The present study is sought to overcome the limitation in previous
research and the goals of present study are:
- To identify the prevalence of psychopathology of normal-tension glaucoma Hong Kong
Chinese Out-patients attending a university-affiliated glaucoma clinic.
- To determine whether there are any differences among NTG patients, patients with
glaucoma other than NTG and control in terms of psychopathology and quality of life.
Designs:
Case-control study to compare among patients with normal-tension glaucoma (NTG), patients
with glaucoma other than normal-tension glaucoma (OTNTG) and control in terms of
psychopathology and quality of life
Status | Active, not recruiting |
Enrollment | 100 |
Est. completion date | June 2010 |
Est. primary completion date | June 2010 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: Inclusion criteria of patients (NTG and OTNTG): - Cantonese-speaking Chinese - Aged from 18 to 65 - Attending university-affiliated glaucoma clinic from August, 2005 to June, 2006 with written consent Inclusion criteria of control - Those just receiving routine fundi examination without any ophthalmologic follow-up afterwards - Cantonese-speaking Chinese - Aged from 18 to 65 - With written consent Exclusion Criteria of cases: Exclusion criteria: - Psychoses - Psychiatric condition warranting hospitalization Exclusion criteria of control - Previous or current ocular or general acute or chronic disease - Taking any medication - Psychoses - Psychiatric condition warranting hospitalization |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
China | Department of Psychiatry, Kowloon Hospital, Hong Kong | Hong Kong |
Lead Sponsor | Collaborator |
---|---|
Chinese University of Hong Kong |
China,
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06000865 -
Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE
|
N/A | |
Recruiting |
NCT06278597 -
Automatic Evaluation of the Anterior Chamber Angle Width by a New Non-contact Optical Device
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03274024 -
The Asia Primary Tube Versus Trab (TVT) Study
|
N/A | |
Completed |
NCT04552964 -
Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma
|
N/A | |
Recruiting |
NCT01957267 -
Functional and Structural Imaging for Glaucoma
|
||
Active, not recruiting |
NCT04624698 -
iStent Inject New Enrollment Post-Approval Study
|
N/A | |
Completed |
NCT04020705 -
The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma
|
N/A | |
Completed |
NCT03150160 -
Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma
|
Phase 4 | |
Not yet recruiting |
NCT05581498 -
Glaucoma Exercise as Medicine Study (GEMS).
|
N/A | |
Recruiting |
NCT02921568 -
Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes
|
N/A | |
Active, not recruiting |
NCT02901730 -
Clinical Study of LPI With Different Laser Wavelengths
|
N/A | |
Completed |
NCT02955849 -
A Trial of China Laser and Surgery Study Glaucoma in Rural China
|
Early Phase 1 | |
Recruiting |
NCT02471105 -
Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml
|
Phase 4 | |
Recruiting |
NCT02554214 -
Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device
|
N/A | |
Active, not recruiting |
NCT02390284 -
Stop Retinal Ganglion Cell Dysfunction Study
|
Phase 3 | |
Completed |
NCT02520674 -
Glaucoma Screening With Smartphone Ophthalmology
|
N/A | |
Completed |
NCT02628223 -
180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma
|
N/A | |
Completed |
NCT02653963 -
Triamcinolone for Ahmed Glaucoma Valve
|
N/A | |
Completed |
NCT02246764 -
Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
|
Phase 3 |